In Depth Research on Global Stem Cell Therapy Market Future Outlook

"Global Stem Cell Therapy Market Future Outlook" Report Highlight:

* Global Stem Cell Market Analysis
* Trends in Stem Cell Research
* Global Stem Cell Market Dynamics: Favorable Factors & Commercialization Challenges
* Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase
* Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies
* Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies
* Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication
* Marketed Stem Cell Therapies Clinical: 2 Therapies (Adipocell® & VesCell™)

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink:https://www.kuickresearch.com/report-Global-Stem-Cell-Therapy-Market-Future-Outlook.php

Table of Contents

1. Introduction to Stem Cells

2. Classification of Stem Cells
2.1 Basis of Ability to Differentiate
2.2 Basis of Origin
2.3 Basis of their Source

3. Different Type of Stem Cell Transplants
3.1 Autologous Stem Cell Transplants
3.2 Allogeneic Stem Cell Transplants
3.3 Syngeneic Stem Cell Transplants

4. Mechanism of Stem Cell Therapy

5. Trends in Stem Cell Research
5.1 Stem Cell Therapy for Cardiovascular Diseases
5.2 Stem Cell Therapy for Cancer Treatment
5.3 Stem Cell Therapy for Central Nervous System Disorders
5.4 Stem Cell Therapy for Ophthalmic Disorders
5.5 Stem Cell Therapy for Metabolic Disorders
5.6 Stem Cell Therapy for Gastrointestinal Diseases

6. Global Stem Cell Market Analysis
6.1 Current Market Scenario
6.2 Global Stem Cell Therapies Pipeline Overview

7. Global Stem Cell Market Dynamics
7.1 Favorable Factors
7.2 Commercialization Challenges

8. Stem Cell Market Future Prospects

9. Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase
9.1 Research
9.2 Preclinical
9.3 Clinical
9.4 Phase-I
9.5 Phase-I/II
9.6 Phase-II
9.7 Phase-III
9.8 Registered

10. Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication
10.1 Adipose Stem Cell Therapy (Adipocell®)
10.2 Angiogenic Cell Precursor Therapy (VesCell™)

11. Discontinued & Suspended Stem Cell Therapies in Clinical Pipeline
11.1 No Development Reported
11.2 Discontinued
11.3 Suspended

12. Competitive Landscape
12.1 Aldagen
12.2 AlloCure
12.3 Anterogen
12.4 Arteriocyte Medical Systems
12.5 Athersys Inc.
12.6 Baxter Healthcare Corporation
12.7 Bioheart
12.8 Cambridge Enterprise Ltd
12.9 Celyad
12.10 Celgene Corporation
12.11 Cellerant Therapeutics
12.12 Cellonis Biotechnologies
12.13 CellPraxis
12.14 Chiesi
12.15 Caladrius
12.16 Cryopraxis
12.17 Cytori Therapeutics
12.18 Gamida Cell
12.19 Genexine
12.20 Geron
12.21 Intrexon Corporation
12.22 K-STEMCELL
12.23 Lifecells LLC
12.24 Medipost
12.25 Medistem Panama
12.26 Mesoblast
12.27 Novartis
12.28 Nuo Therapeutics
12.29 Ocata Therapeutics
12.30 OmniCyte Ltd
12.31 OncoMed
12.32 Osiris Therapeutics
12.33 Pharmicell
12.34 Pluristem Therapeutics
12.35 Promethera Biosciences
12.36 ReNeuron
12.37 Stem Cell Sciences (SCS)
12.38 Stem Cells
12.39 Stemedica Cell Technologies
12.40 TCA Cellular Therapy
12.41 TheraVitae
12.42 TiGenix
12.43 Vericel Corporation

Figure 1-1: Properties of Stem Cells
Figure 1-2: Utility of Stem Cells
Figure 1-3: Benefits of Stem Cells
Figure 1-4: Limitations of Stem Cells
Figure 2-1: Type of Stem Cells on the Basis of Ability to Differentiate
Figure 2-2: Type of Stem Cells on the Basis of Origin
Figure 2-3: Types of Stem Cells on the Basis of their Source
Figure 2-4: Different Sources of Autologous Stem Cell
Figure 3-1: Different Stem Cell Transplants
Figure 4-1: Source of Hematopoietic Stem Cells
Figure 4-2: Mechanism of Stem Cells Blood Related Diseases
Figure 4-3: Mechanism of Skin treatment by Stem Cells
Figure 4-4: Mechanism of Stem Cell Diabetes Treatment
Figure 5-1: Relevant Type of Stem Cells for CVS
Figure 5-2: Proposed Mechanism of Stem Cell Activity
Figure 6-1: Difference between Autologous & Autogenic HSCTs
Figure 6-2: Global Stem Cell Market Opportunity (US$ Billion), 2015-2020
Figure 6-3: Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015
Figure 6-4: Global Stem Cell Therapies Clinical Pipeline by Phase (Number), 2015
Figure 6-5: No Development Reported Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015
Figure 6-6: No Development Reported Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015
Figure 6-7: Discontinued Global Stem Cell Therapies Clinical Pipeline by Phase (%), 2015
Figure 6-8: Discontinued Global Stem Cell Therapies Clinical Pipeline by Phase (Number), 2015
Figure 7-1: Global Stem Cell Market Favorable Parameters
Figure 7-2: Global Stem Cell Market Commercialization Challenges
Figure 12-1: Anterogen - Clinical Pipeline
Figure 12-2: Arteriocyte Medical Systems Clinical Pipeline
Figure 12-3: Bioheart-Clinical Pipeline
Figure 12-4: Celgene-Clinical Pipeline
Figure 12-5: Cellerant-Therapeutics Clinical Pipeline
Figure 12-6: Caladrius-Clinical Pipeline
Figure 12-7: Gamida Cell- Clinical Pipeline
Figure 12-8: Genexie-Clinical Pipeline
Figure 12-9: Mesoblast Clinical Pipeline
Figure 12-10:OncoMed-Clinical Pipeline
Figure 12-11: Osiris Therapeutics- Clinical Pipeline
Figure 12-12: Pharmicell-Clinical Pipeline
Figure 12-13: Promethera- Clinical Pipeline
Figure 12-14: ReNeuron-Clinical Pipeline
Figure 12-15: Stem Cell-Clinical Pipeline
Figure 12-16: Vericel –Clinical Pipeline

Table 2-1: Difference between Embryonic, Adult & Induced Stem Cells
Table 3-1: Comparison between Different Types of Stem Cell Transplants
Table 3-2: Few Autologous Stem Cell Therapies under Development
Table 4-1: Different Stem Cells used for Skin Treatment

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
India
+91-11-47067990

This release was published on openPR.